Appendix 1A — ASX Listing Application and Agreement

Jun 21, 2017
Posted in: Investor updates

Home » Appendix 1A — ASX Listing Application and Agreement

Appendix 1A — ASX Listing Application and Agreement

Jun 21, 2017
Posted in: Investor updates

Appendix 1A — ASX Listing Application and Agreement is required by listing rule 1.7 to be used by an entity seeking admission to the official list as an ASX Listing.
View Appendix 1A — ASX Listing Application and Agreement.

Quarterly Activity Report – Quarter ending 31 December 2023

January 31, 2024

Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal

[VIDEO] EGM Recording – 13 November 2023

November 14, 2023

https://youtu.be/hThLkmpJPW0 EGM 13 November 2023 Video transcript: Welcome and thanks for joining us. Both those joining virtually and those in person. As the time is

Quarterly Activity Report – Quarter ending 30 September 2023

October 31, 2023

Highlights: Announced preliminary performance of MagSense® HER2 Imaging Agent in phase 1 study after study closure (post quarter end) Entered a strategic partnership with Prestige

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Appendix 1A — ASX Listing Application and Agreement

Appendix 1A — ASX Listing Application and Agreement

Related Articles

Quarterly Activity Report – Quarter ending 31 December 2023

[VIDEO] EGM Recording – 13 November 2023

Quarterly Activity Report – Quarter ending 30 September 2023

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list